Angel Medical Systems
Jacqueline Finley is currently a Clinical Project Manager at Avertix Medical, overseeing the development of the world's first FDA-approved implantable cardiac monitor with ACS detection technology. Additionally, Finley serves as an Undergraduate Researcher at Rutgers Addiction Research Center, focusing on neural circuits related to compulsive drug-seeking and the development of pharmaceuticals for binge eating disorders. As a Leadership Scholar in the Institute for Women's Leadership, Jacqueline is being prepared for innovative and socially responsible leadership roles. Finley is also the founder of Rhythm & Recovery, a dance therapy initiative for mental health, and is an active member of Into the Light, promoting mental health awareness. Previous experience includes serving as president of GlobeMed, where efforts were directed toward global health equity, and working as a Medical Scribe to enhance patient care. Jacqueline holds a Bachelor's degree in Biology from Rutgers University and previously earned an IB Diploma at Biotechnology High School.
This person is not in any teams
Angel Medical Systems
1 followers
For over 17 years, Angel Medical Systems has been committed to advancing life-sustaining patient care and the long-term management of High-Risk Coronary Artery Disease through innovation, clinical science, and collaboration. Angel Medical Systems, Inc. has developed the AngelMed Guardian®, the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS) including heart attacks.